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Background
Incidence of NAS has increased in the US from 1.5 to
8.0 cases per 1000 hospital births from 2004 to 2014.
Among 28 states with available data, Maine had the
third highest annual change in incidence rate from
2009 to 2012, with 30.4 NAS cases per 1000 hospital
births. As rates of NAS appeared to be approximately 5
times higher in Maine than the national average, this
warranted further examination of trends of NAS among
hospital births in Maine using more recent data.
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Objectives
The objective of this poster is to share the results from
our exploratory study on trends in diagnoses of
neonatal abstinence syndrome (NAS) at newborn
hospitalization in Maine using state-level hospital
discharge data from 2009 to 2018.

Methods
We used hospital discharge data collected by the
Maine Health Data Organization. We identified
neonates among hospital discharges in Maine from
2009-2018 by matching date of birth to date of
admission for persons under 1 year of age (n=123,519
neonates). We used International Classification of
Diseases, Clinical Modification (ICD-CM) codes to
categorize neonates diagnosed with NAS. For ICD-9-CM
(2009 through 9/2015), codes for NAS included: 779.5,
779.4. For ICD-10 CM (10/2015 through 2018), we
followed the 2019 Council of State and Territorial
Epidemiologists’ (CSTE) Tier 2 Case Classification
scheme for NAS when using administrative data. Our
primary NAS case definition was CSTE’s confirmed or
suspect case of NAS. Our expanded NAS case definition
also included codes for neonates affected by other
unspecified maternal medication, which could include
in utero opioid exposure (Table 1). Using each
definition, JoinPoint regression analysis was used to
model trends over time and identify any change in
slope (Figure 1 and 2).

Table 1: ICD-10-CM codes associated with
primary and expanded NAS case definitions
Definition
Primary
NAS
case
definition

Interpretation
Confirmed or
Suspected NAS
definition

Codes

P96.1 – Neonatal Abstinence Syndrome
P04.14 – Newborn affected by maternal
use of opiates
P04.17 – Newborn affected by maternal
use of sedative-hypnotics
P04.1A – Newborn affected by maternal
use of anxiolytics
Expanded Confirmed or In addition to codes listed above:
NAS case Suspected NAS P04.1 – Newborn affected by other
maternal medication
definition* and
P04.40
–
Newborn
affected
by
maternal
Unspecified
use
of
unspecified
drugs
of
addiction
drug codes
P04.18 – Newborn affected by other
maternal medication
P04.19 – Newborn affected by maternal
use of unspecified medication
P04.49 – Newborn affected by maternal
use of other drugs of addiction
*Separate ICD-10 CM codes exist for newborns affected by maternal use of chemotherapy,
cytotoxic drugs, anticonvulsants, antidepressants, amphetamines, sedative hypnotics,
anxiolytics, tobacco, alcohol, cocaine, hallucinogens, nutritional chemical substances,
environmental chemical substances, noxious substances, cannabis, other maternal noxious
substances, and noxious substance, unspecified.

Results
Using our primary NAS case definition, diagnoses of NAS
increased from 2009 to 2013 (24 to 43 per 1,000 births), and
then decreased from 2013 to 2018 (43 to 28 per 1,000 births),
as seen in Figure 1. Using our expanded NAS case definition,
NAS increased, in a linear fashion, from 2009-2018 (24 to 50
per 1,000 births), as seen in Figure 2.

Conclusion
Due to the difference in trends observed based on NAS
definition, caution should be used when interpreting NAS
trends using hospital discharge data from Maine. Further
research should utilize hospital-level, electronic medical record
reviews to identify if codes for newborns affected by
unspecified maternal drugs include opioid exposure.
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